StockCall Pre-Market Review on AMRN, ARAY, ATRS, and ANTH

ARAY, AMRN, AIS, ANTH
StockCall Pre-Market Review on AMRN, ARAY, ATRS, and ANTH

StockCall.com Provides Stock Research on Amarin Corp. plc, Accuray Inc., Antares Pharma Inc., and Anthera Pharmaceuticals Inc.

New York City, New York -- (May 20, 2013)

The healthcare sector has been facing significant challenges over the last few years. One of the biggest challenges is the implementation of Affordable Care Act (ACA), which was upheld by the Supreme Court last year. The ACA, which is the biggest overhaul of the healthcare industry in decades, will go into full effect by 2014. The reform is expected to result in higher costs for the healthcare industry. However, the ACA has generally been welcomed by healthcare companies as the increase in the number of insured individuals will eventually benefit them. Healthcare stocks ended mostly higher on Friday, tracking gains in the broad market. Among the major movers in the sector were Amarin Corporation Plc (NASDAQ: AMRN), Accuray Incorporated (NASDAQ: ARAY), Antares Pharma Inc. (NASDAQ: ATRS), and Anthera Pharmaceuticals Inc. (NASDAQ: ANTH). StockCall analysts initiated preliminary technical research on AMRN, ARAY, ATRS, and ANTH. These free reports are accessible by signing today at

www.stockcall.com/register

Shares of Amarin Corporation Plc edged lower on Friday even as the broad market rallied. The stock traded between $7.07 and $7.39 before finishing the day 1.24% lower at $7.14 on volume of 2.62 million. Amarin’s shares have now fallen more than 7.80% in the last three trading sessions. Year-to-date, the stock is down more than 11.70% as compared to a gain of over 16.90% for the S&P 500. The drug maker’s shares slipped below their 50-day moving average last week which is a bearish signal. The free technical analysis on AMRN is available by signing up at

www.StockCall.com/AMRN052013.pdf

Shares of Accuray Incorporated rose sharply on Friday, reversing some of the losses from previous trading sessions. The stock ended the day 2.14% higher at $5.26 on volume of 818,100. Despite the gains on Friday, Accuray’s shares have fallen nearly 2.60% in the last three sessions. The stock, however, is still trading above its 50-day and 200-day moving averages which suggest that market sentiment has been bullish on the stock. The medical appliances & equipment company’s shares are currently facing resistance at around $5.50. Register now to download the free research on ARAY at

www.StockCall.com/ARAY052013.pdf

Another major gainer in the healthcare sector on Friday was Antares Pharma Inc. Shares of the Ewing, New Jersey-based company rose to an intraday high of $4.07 before finishing the day 2.01% higher at $4.06 on above average volume of 1.30 million. Antares’ shares have now gained 4.10% in the last three trading sessions which indicates that market sentiment has been bullish on the stock. The stock has also crossed above its 200-day moving average which further confirms the positive trend. Free report on ATRS can be accessed by registering at

www.StockCall.com/ATRS052013.pdf

Shares of Anthera Pharmaceuticals Inc. rallied in Friday’s trading session. The stock closed 4.83% higher at $0.608 on volume of 623,800. Despite the significant gains, Athera’s shares fell nearly 0.40% in the last three trading sessions. The stock is currently trading close to its 52-week low of $0.49. The company’s shares are also trading below their 50-day moving average which is a bearish signal. The stock currently faces stiff resistance at around $0.650. Year-to-date, shares of the company have fallen more than 1.60%, underperforming the broad market.Register withStockCall and download the research on ANTH for free at

www.StockCall.com/ANTH052013.pdf

About StockCall.com

StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines. Sign up today to talk to our financial analyst at

www.stockcall.com

Contact Person:

William T. Knight

Email: info@stockcall.com

Contact Number: (646) 396-9857 (9:00 am EST – 01:30 pm EST)


Rate this press release
0 stars
v
Usefulness

Clarity

Credibility
Add to favourites icon Add to favourites